0001562180-19-003935.txt : 20190715
0001562180-19-003935.hdr.sgml : 20190715
20190715090221
ACCESSION NUMBER: 0001562180-19-003935
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190711
FILED AS OF DATE: 20190715
DATE AS OF CHANGE: 20190715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHEINBERG DAVID A
CENTRAL INDEX KEY: 0001250316
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23143
FILM NUMBER: 19954192
MAIL ADDRESS:
STREET 1: 325 CENTRAL PARK W
STREET 2: APT 38
CITY: NEW YORK
STATE: NY
ZIP: 10025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000835887
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133379479
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE WORLD TRADE CENTER
STREET 2: 47TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
BUSINESS PHONE: 646-975-2500
MAIL ADDRESS:
STREET 1: ONE WORLD TRADE CENTER
STREET 2: 47TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10007
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-07-11
false
0000835887
PROGENICS PHARMACEUTICALS INC
PGNX
0001250316
SCHEINBERG DAVID A
ONE WORLD TRADE CENTER
47TH FLOOR, SUITE J
NEW YORK
NY
10007
true
false
false
false
Non-Qualified Stock Option (Right to Buy)
5.74
2019-07-11
4
A
false
25000.00
0.00
A
2029-07-11
Common Stock
25000.00
25000.00
D
The stock options become exercisable in 12 monthly installments, commencing one month from the grant date.
/s/ David A. Scheinberg
2019-07-15